KK

Kazuhiko Kato

Director Director DIN 08226329
DIN 08226329 First appointment Oct 2018 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2018
Shareholding value Locked Premium profile

About Kazuhiko Kato

Data last updated:

Kazuhiko Kato has 8 years in corporate governance. Formerly with 1 company, such as Neoaska Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08226329
Primary Designation Director
First Appointment 03 Oct 2018
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Neoaska Pharma Private Limited U74999TG2017PTC119969
Director03 Oct 20182017Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Neoaska Pharma Private Limited
Premium access

Shareholding and investment profile for Kazuhiko Kato

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kazuhiko Kato

Kazuhiko Kato has 8 years in corporate governance. Formerly with 1 company, such as Neoaska Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Kazuhiko Kato is associated with 0 companies as a director.

Kazuhiko Kato has expertise in General Business.

Kazuhiko Kato has 8 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available